Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

导出 LinkOut

翻译打印收藏纠错

作者： Adem,Albayrak ^[1] ; Ana C,Garrido-Castro ^[2] ; Marios,Giannakis ^[3] ; Renato,Umeton ^[2] ; Monica Devi,Manam ^[3] ; Elizabeth H,Stover ^[4] ; Rebecca L,Porter ^[1] ; Bruce E,Johnson ^[5] ; Kai-Li,Liaw ^[6] ; Mayur,Amonkar ^[2] ; Alanna J,Church ^[3] ; Katherine A,Janeway ^[2] ; Jonathan A,Nowak ^[3] ; Lynette,Sholl ^[2] ; Nancy U,Lin ^[3] ; Jason M,Johnson ^[7]

作者单位： Informatics and Analytics Department, Dana-Farber Cancer Institute, Boston, MA. ^[1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. ^[2] Harvard Medical School, Boston, MA. ^[3] Broad Institute of MIT and Harvard, Cambridge, MA. ^[4] Massachusetts Institute of Technology, Cambridge, MA. ^[5] Department of Pathology, Brigham and Women's Hospital, Boston, MA. ^[6] Merck, Kenilworth, NJ. ^[7] Department of Pathology, Boston Children's Hospital, Boston, MA. ^[8] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA. ^[9]

DOI 10.1200/PO.20.00185

PMID 35050773

发布时间 2023-08-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2020年4卷

1084-1097页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除